[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 596 Introduced in Senate (IS)]
<DOC>
114th CONGRESS
2d Session
S. RES. 596
Designating September 2016 as ``Pulmonary Fibrosis Awareness Month''.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
September 29, 2016
Mr. Coons (for himself, Mr. Kirk, and Mr. Murphy) submitted the
following resolution; which was referred to the Committee on the
Judiciary
_______________________________________________________________________
RESOLUTION
Designating September 2016 as ``Pulmonary Fibrosis Awareness Month''.
Whereas pulmonary fibrosis is a debilitating and ultimately fatal condition that
causes progressive scarring in the lungs and generally has no known
definitive cause;
Whereas as many as 200,000 individuals in the United States are known to suffer
from pulmonary fibrosis, the majority of whom are between the ages of 50
and 75;
Whereas the average survival rate for the idiopathic form of pulmonary fibrosis
is just 2.8 years and up to 80 percent of idiopathic pulmonary fibrosis
patients die within 5 years of diagnosis;
Whereas pulmonary fibrosis takes the lives of 40,000 individuals in the United
States each year, approximately 1 death every 13 minutes;
Whereas many patients with pulmonary fibrosis are misdiagnosed for 1 year or
longer after the patients are presenting with pulmonary fibrosis
symptoms;
Whereas as of September 2016, there are no biomarkers for screening and testing
for pulmonary fibrosis;
Whereas a cure or drug that is effective for all pulmonary fibrosis patients
that would extend life or universally improve symptoms does not exist;
Whereas the symptoms of pulmonary fibrosis vary from person to person and
include shortness of breath, a dry cough, fatigue, weight loss, and
aching muscles and joints;
Whereas volunteers, researchers, caregivers, and medical professionals are
working to improve the quality of life for individuals with pulmonary
fibrosis and the families of those individuals; and
Whereas developing more effective treatments for pulmonary fibrosis and
providing access to quality care to individuals with pulmonary fibrosis
requires increased research, education, and community support services:
Now, therefore, be it
Resolved, That the Senate--
(1) designates September 2016 as ``Pulmonary Fibrosis
Awareness Month'';
(2) supports the goals and ideals of Pulmonary Fibrosis
Awareness Month;
(3) continues to support more robust and accelerated
research to develop more effective treatments for pulmonary
fibrosis and to ultimately find a cure for the disease;
(4) recognizes the courage and contributions of individuals
with pulmonary fibrosis who participate in vital clinical
trials to advance the knowledge of the disease; and
(5) commends the dedication of organizations, volunteers,
researchers, and millions of individuals in the United States
and abroad working to improve the quality of life for
individuals with pulmonary fibrosis and the families of those
individuals.
<all>